Effect of neuropeptides on cognitive function

Experimental Gerontology

Volumn 32, Issue 4-5, 1997, Pages 451-469

  Bennett, G W ^a   Ballard, T M ^a   Watson, C D ^a   Fone, K C F ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Behavior; Cognitive function; Neuropeptides; TRH

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GALANIN; NEUROPEPTIDE; NEUROPEPTIDE Y; PROTIRELIN; SOMATOSTATIN; SUBSTANCE P; VASOPRESSIN;

AGING; ANIMAL BEHAVIOR; COGNITION; CONFERENCE PAPER; HUMAN; MEMORY; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL;

AGING; ANIMALS; BEHAVIOR; COGNITION; HUMANS; MEMORY; NEUROPEPTIDES; THYROTROPIN-RELEASING HORMONE;

ANIMALIA; RODENTIA;

EID: 0030816059     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(96)00159-3     Document Type: Conference Paper

References (86)

1. AGGLETON, J.P., KEITH, A.B., and SAHGAL, A. Both fornix and anterior thalamic, but not mammillary lesions disrupt delayed non-matching to position memory in rats. Behav. Brain. Res. 44, 151-161, 1991.
2. ALTAVISTA, M.C., ROSSI, P., BENTIVOGLIO, A.R., CROCIANI, P., and ALBANESE, A. Ageing is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res. 508, 51-59, 1990.
3. ASPLEY, S. and FONE, K.C.F. Galamin fails to alter either acquisition of a two trail per day water maze task or neurochemical markers of cholinergic or serotonergic neurons in adult rats. Brain Res. 662, 330-336, 1993.
4. BALLARD, T.M., HUNTER, A.J., and BENNETT, G.W. Effect of TRH analogue, RX77368 on a working memory test in AMPA-induced septal-hippocampal lesioned rats. J. Psychopharmacol. 95, 25, 1995.
5. BALLARD, T.M., HUNTER, A.J., and BENNETT, G.W. The TRH analogue, RX77368 improves working memory in AMPA-induced septal-hippocampal lesioned rats. Br. J. Pharmacol. 117, 174P, 1996a.
6. BALLARD, T.M., HUNTER, A.J., and BENNETT, G.W. Effect of thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test. Psychopharmacology 127, 265-275, 1996b.
7. BARTUS, R.T., DEAN, R.L., BEER, B., and LIPPA, A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-417, 1982.
8. BEAL, M.F. and MAZUREK, M.F. Substance P like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology 37, 1205-1209, 1987.
9. BENNETT, G.W., MARSDEN, C.A., FONE, K.C.F., JOHNSON, J.V., and HEAL, D.J. TRH-catecholamine interactions in brain and spinal cord. Ann. NY Acad. Sci. 553, 106-120, 1989.
10. BISSETTE, G., REYNOLDS, G.P., KILTS, C.D., WIDERLOV, E., and NEMEROFF, C.B. Corticotrophin-releasing factor like immunoreactivity in senile dementia of the Alzheimer type. JAMA 254, 3067-3069, 1985.
11. 1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task. Psychopharmacology (Berlin) 116, 135-142, 1994.
12. CRAWLEY, J.N. Functional interactions of galanin and acetylcholine: Relevance to memory and Alzheimer's disease. Behav. Brain Res. 57, 133-141, 1993.
13. DE WIED, D. and VAN REE, J.M. Neuropeptides, mental performance and ageing. Life Sci. 31, 709-719, 1982.
14. DECKER, M.W. The effects of ageing on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res. Rev. 12, 423-438, 1987.
15. DUNNETT, S.B. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-forni on delayed matching in rats. Psychopharmacology (Berlin) 87, 357-363, 1985.
16. DUNNETT, S.B., BADMAN, F., ROGERS, D.C., EVENDEN, J.L., and IVERSEN, S.D. Cholinergic grafts in the neocortex or hippocampus of aged rats: Reduction of delay-dependent deficits in the delayed non-matching to position task. Exp. Neurol. 102, 57-64, 1988.
17. DUNNETT, S.B., ROGERS, D.C., and JONES, G.H. Effects of nucleus basalis magnocellularis lesions in the rat on delayed-matching and non-matching to position tasks. Eur. J. Neurosci. 1, 395-406, 1989.
18. DUNNETT, S.B., EVERITT, B.J., and ROBBINS, T.W. The basal forebrain-cortical cholinergic system: Interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14, 494-501, 1991.
19. EYMIN, C., CHAMPIER, J., DUVERNOY, H.M., MARTIN, D., KNOPP, N., and JORDAN, D. Distribution of thyrotrophin-releasing hormone binding sites: Autoradiographic study in infant and adult human hippocampal formation. Brain Res. 605, 139-146, 1993.
20. FADEN, A.I., SACKSEN, J., and NOBLE, L.J. Structure-activity relationships of TRH analogues in experimental spinal injury. Brain Res. 448, 287-293, 1988.
21. FIBIGER, H.C. Cholinergic mechanisms in learning and memory and dementia: A review of recent evidence. Trends Neurosci. 14, 220-223, 1991.
22. FISCHER, W., GAGE, S.H., and BJORKLUND, A. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1, 34-45, 1989.
23. FISONE, G., WU, C.F., CONCOLO, S., NORDSTROM, O., BRYNNE, N., BARTFAI, T., MEALANDER, T., and HOKFELT, T. Galanin inhibits acetylcholine release in the ventral hippocampus in the rat; Histochemical, autoradiographical in vivo and in vitro studies. Proc. Natl. Acad. Sci. USA 84, 7339-7343, 1987.
24. FITZGERALD, L.W., and DOLKA, C.P.J. Morris water task impairment and hypoactivity following cystamine-induced reductions of somatostatin-like immunoreactivity. Brain Res. 505, 246-250, 1989.
25. FLOOD, J.F., BAKER, M.L., HERNANDEZ, E.N., and MORLEY, J.E. Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res. 503, 73-82, 1989.
26. GEULA, C., and MESULAM, M.M. Cortical cholinergic fibres in ageing and Alzheimer's disease. A morphometric study. Neuroscience 33, 469-481, 1989.
27. GIOVANNINI, M.G., CASAMENTI, F., NISTRI, A., PAOLI, F., and PEPEU, G. Effect of TRH on acetylcholine release from different brain areas investigated by microdialysis. Br. J. Pharmacol. 102, 363-368, 1991.
28. GIVENS, B.S., OLTON, D.S., and CRAWLEY, J.N. Galanin in the medial septal area impairs working memory. Brain Res. 582, 71-77, 1992.
29. GOTTFRIES, C.G. Neurochemical aspects on ageing and diseases with cognitive impairment. J. Neurosci. Res. 27, 541-547, 1990.
30. GRIFFITHS, E.C. Clinical applications of thyrotrophin-releasing hormone. Clin. Sci. 73, 449-457, 1987.
31. GUILOFF, R.T. Use of TRH analogues in motor neurone disease. Ann. NY Acad. Sci. 553, 399-421, 1989.
32. HAGAN, J.J., and MORRIS, R.M. The cholinergic hypothesis of memory: Review of animal experiments. In: Handbook of Psychopharmacology Iversen, L.C., Iversen, S., and Suyder, S.H. (Editors), Vol 20, pp. 237-323, Plenum Press, London, 1988.
33. HAGAN, J.J., SALAMONE, J.D., SIMPSON, J., IVERSEN, S.D., and MORRIS, R.G.M. Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis. Behav. Brain Res. 27, 9-20, 1988.
34. HASENOHRL, R.U., HUSTON, J.P., and SOHUURMAN, T. Neuropeptide substance P improves water maze performance in aged rats. Psychopharmacology (Berlin) 101, 23-26, 1990.
35. HOKFELT, T., FUXE, K., JOHANSSON, O., JEFFCOATE, S., and WHITE, N. Distribution of thyrotrophin-releasing hormone (TRH) in the central nervous system as revealed by immunohistochemistry. Eur. J. Pharmacol. 34, 389-392, 1975.
36. HOLADAY, J.W., LONG, J.B., MARTINEZ-ARIZALA, A., CHEN, H., REYNOLDS, D.G., and GURLL, N.J. Effects of TRH in circulatory shock and central nervous system ischemia. Ann. NY Acad. Sci. 553, 370-379, 1989.
37. HORITA, A., CARINO, A., ZABAWSKA, J., and LAI, H. TRH analogue MK771 reverses neurochemical and learning deficits in medial septal-lesioned rats. Peptides 10, 121-124, 1989.
38. HUTSON, P.H., SEMARK, J.E., and MIDDLEMISS, D.N. The TRH analogue MK-771 increases rat hippocampal but not striatal acetylcholine release in vivo. Br. J. Pharmacol. 100, 310P, 1990.
39. JACKSON, J.M.D. Thyrotrophin-releasing hormone (TRH). N. Engl. J. Med. 306, 145-155, 1982.
40. JIANG, H-K., OWYANG, V., HONG, J-S., and GALLAGHER, M. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc. Natl. Acad. Sci. USA 86, 2948-2951, 1989.
41. KALIVAS, P.W., and HORITA, A. Thyrotrophin-releasing hormone neurogenesis of actions in the pentobarbital narcotised rat. J. Pharmacol. Exp. Ther. 212, 203-210, 1980.
42. KALRA, S.P., SAHU, A., and KALRA, P.S. Aging of the neuropeptidergic signals in rats. J. Reprod. Fertil. Suppl. 46, 11-19, 1993.
43. KARDON, F.C., WINOKUR, A., and UTIGER, R.D. Thyrotrophin-releasing hormone in rat spinal cord. Brain Res. 122, 578-581, 1977.
44. KASTIN, A.J., EHRENSING, R.H., SCHALCH, D.S., and ANDERSON, M.S. Improvement in mental depression with decreased thyrotrophin response after administration of TRH. Lancet 2, 740-742, 1972.
45. KELLY, J.A. Thyrotrophin-releasing hormone: Basis and potential for its therapeutic use. Essays Biochem. 30, 133-149, 1995.
46. KELSEY, J.E., and LANDRY, B.A. Medial septal lesions disrupt spatial mapping ability in rats. Behav. Neurosci. 102, 289-293, 1988.
47. KHAN, A., LAI, H., UKAI, Y., and MIROLD, M.H. NS-3, a TRH analogue reverses repeated ECS-induced deficits in water maze performance in the rat. Pharmacol. Biochem. Behav. 47, 477-481, 1994.
48. KOSKINEN, L-OD. Cerebral and peripheral blood flow effects of TRH in the rat - A role of vagal nerves. Peptides 10, 933-938, 1989.
49. LAMOUR, Y., DUTAR, P., and JOBERT, A. Effects of TRH, cyclo-(His-Pro) and (3-Me-His) TRH on identified septohippocampal neurons in the rat. Brain Res. 331, 341-347, 1985.
50. MATSUISHI, T., YANO, E., INANGA, K., TERASAWA, K., ISHIHARA, O., SHIOTSUKI, Y., KATAFUCHI, Y., AOKI, N., and YAMASHITA, F. A pilot study on the anticonvulsive effects of a thyrotrophin-releasing hormone analogue in intractable epilepsy. Brain Dev. 5, 421-428, 1983.
51. McALONAN, G.M., DAWSON, G.R., WILKINSON, L.S., ROBBINS, T.W., and EVERITT, B.J. The effects of AMPA-induced lesions of the medial septum and vertical limb nucleus of the diagonal band of Broca on spatial delayed non-matching to sample and spatial learning in the water maze. Eur. J. Neurosci. 7, 1034-1049, 1995a.
52. McALONAN, G.M., WILKINSON, L.S., ROBBINS, T.W., and EVERITT, B.J. The effects of AMPA-induced lesions of the septo-hippocampal cholinergic projection on aversive conditioning to explicitly and contextual cues and spatial learning in the water maze. Eur. J. Neurosci. 7, 281-292, 1995b.
53. McNAMARA, R.K., and SKELTON, R.W. The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res. Rev. 18, 33-49, 1993.
54. MELLOW, A.H., ARONSON, S.M., GIORDANI, B., and BERENT, S. A peptide enhancement strategy in Alzheimer's disease; Pilot study with TRH/physostigmine infusions. Biol. Psychol. 34, 271-273, 1993.
55. MELLOW, A.H., SUNDERLAND, T.S., COHEN, R.M., LAWLOR, B.A., HILL, L.J., NEWHOUSE, P.A., COHEN, M.R., and MURPHY, D.L. Acute effects of high-dose thyrotrophin-releasing hormone infusions in Alzheimer's disease. Psychopharmacology (Berlin) 98, 403-407, 1989.
56. METCALF, G., and JACKSON, M.D. Thyrotrophin-releasing hormone; Biomedical significance. Ann. NY Acad. Sci. 553, 269-313, 1989.
57. METCALF, G. Regulatory peptides as a source of new drugs - The clinical prospects for analogues of TRH which are resistant to metabolic degradation. Brain Res. Rev. 4, 389-402, 1982.
58. MITSUMA, T., and NOGIMORI, T. Influence of the route of administration of thyrotrophin-releasing hormone concentration in the mouse brain. Experientia 39, 620-623, 1983.
59. MOLCHAN, S.E., MELLOW, A.H., HILL, J.L., WEINGARTNER, H.J., MARTINEZ, R.A., VITIELLO, B., and SUNDERLAND, T. The effects of thyrotrophin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers. J. Psychopharmacol 6, 489-500, 1992.
60. MOLCHAN, S.E., MELLOW, A.H., LAWLOR, B.A., WEINGARTNER, H.J., COHEN, R.M., COHEN, M.R., and SUNDERLAND, T. TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacology (Berlin) 100, 84-89, 1990.
61. MORLEY, J.E. Extrahypothalamic thyrotrophin-releasing hormone (TRH) - Its distribution and its function. Life Sci. 25, 1539-1550, 1979.
62. MORRIS, R.G.M. Spatial localisation does not require the presence of local cues. Learn. Mot. 12, 239-260, 1981.
63. MORRIS, R.G.M. Developments of a water-maze procedure for studying spatial learning. J. Neurosci. Methods 11, 47-60, 1984.
64. NICHOLL, R.A. Excitatory action of TRH on spinal motoneurons. Nature 265, 242-243, 1977.
65. NILSSON, O.G., LEANZA, G., ROSENBLAD, C., LAPPI, D.A., WILEY, R.G., and BJORKLUND, A. Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuroreport 3, 1005-1008, 1992.
66. OGREN, S.O., HOKFELT, T., KASLI, K., LANGEL, U., and BARTFAI, T. Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience 51, 1-5, 1992.
67. OKADA, M. Effects of a new TRH analogue YM-14673, on the in vivo release of acetylcholine as measured by intracerebral dialysis in rats. J. Neurochem. 56, 1544-1547, 1991.
68. PAGE, K.J., EVERITT, B.J., ROBBINS, T.W., MARSTON, H.M., and WILKINSON, L.S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA-induced and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: Differential dependence on cholinergical neuronal loss. Neuroscience 43, 457-472, 1991.
69. PEPEU, G., CASAMENTI, I., MARCNCINI P., and SCALI, C. The brain cholinergic system in aging mammals. J. Reprod. Fertil. Suppl. 46, 155-162, 1993.
70. ROSSOR, M. Neurochemical studies in dementia. In: Handbook of Psychopharmacology, Iversen, L.C., Iversen, S., and Suyder, S.H. (Editors), Vol. 20, pp. 1-48, Plenum Press, London, 1988.
71. ROSSOR, M.N., IVERSEN, L.L., REYNOLDS, G.P., MOUNTJOY, C.Q., and ROTH, M. Early and late onset types of Alzheimer's disease are neurochemically distinct. Br. Med. J. 288, 961-964, 1984.
72. SAHGAL, A. Contrasting effects of vasopressin, desglycimamide-vasopressin and amphetamine on a delayed non-matching to position task in rats. Psychopharmacology (Berlin) 93, 243-249, 1987.
73. SCHMIDT-ACJERT, K.M., ASKANSAS, V., and ENGEL, W.K. Thyrotrophin-releasing hormone enhances choline acetyltransferase and creatine kinase in cultured spinal ventral neurons. J. Neurochem. 43, 586-589, 1984.
74. SHARP, T., BENNETT, G.W., MARSDEN, C.A., and TULLOCH, I.F. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues. Regul. Pept. 9, 305-315, 1984a.
75. SHARP, T., TULLOCH, I.F., BENNETT, G.W., MARSDEN, C.A., METCALF, G., and DETTMAR, P.W. Analeptic effects of centrally injected TRH and analogues of TRH in the pentobarbitone-anaesthetised rat. Neuropharmacology 23, 339-348, 1984b.
76. SHREWSBURY-GEE, J., LYE, R.H., LATHAM, A., and SLATER, P. The effects of TRH analogues on cerebral ischemia produced by middle artery occlusion in the rat. Exp. Brain Res. 70, 342-350, 1988.
77. SILLS, M.A., MELLOW, A.M., SUNDERLAND, T., and JACOBOWITZ, D.M. Central, muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analogue, MK771 in the rat. Brain Res. 453, 385-388, 1988.
78. WALLIN, A., CARLSSON, A., ECKMAN, R., GOTTFRIES, C.G., KARLSSON, I., VENNERHOLM, L., and WINDERLOV, E. Hypothalamic monoamines and neuropeptides in dementia. Eur. J. Neuropsychopharmacol. 1, 165-168, 1990.
79. WATSON, C.D., BROWNING, B.S., FONE, K.C.F., and BENNETT, G.W. Effects of chronic administration of a TRH analogue (RX77368) and atropine on cognitive behavior and brain biochemistry in the rat. Br. J. Pharmacol. 100, 312P, 1990.
80. WATSON, C.D., FONE, K.C.F., and BENNETT, G.W. Effects of scopolamine treatment on water maze behavior and brain TRH and choline acetyltransferase levels in the rat. Neurosci. Lett. 42, 533, 1992.
81. WATSON, C.D., FONE, K.C.F., JACKSON, H.C., and BENNETT, G.W. Effect of the stable TRH analogue RX77368 (pGlu-His-3,3-dimethylProNH2) on two cognitive tests in the senescent rat. Br. J. Pharmacol. 110, 104P, 1993.
82. WATSON, C.D., HEWITT, M.J., FONE, K.C.F., JACKSON, H.C., and BENNETT, G.W. Behavioral effects of scopolamine and the TRH analogue RX77368 on radial maze performance in the rat. J. Psychopharmacol. 8, 88-93, 1994.
83. WILLIAMS, D.B., and WINDBANK, A.J. Motor neurone disease (Amyotrophic Lateral Sclerosis). Mayo Clin. Proc. 66, 54-82, 1991.
84. YAMAMOTO, M., and SHIMIZU, M. Effects of a new analogue of TRH on pentobarbital-induced sleep time in rodents. Neuropharmacology 28, 863-866, 1989.
85. YARBROUGH, G.G. Thyrotrophin-releasing hormone and CHS cholinergic neurons. Life Sci. 33, 111-118, 1983.
86. YEHUDA, S. The effects of alpha-MSH, TRH and AVP on learning and memory, pain threshold and motor activity: Preliminary results. Int. J. Neurosci. 332, 703-709, 1987.